← Back to headlines
Teva Gains Approval for Biosimilar of Amgen's Prolia
Teva Pharmaceutical Industries has received approval for its biosimilar version of Amgen's osteoporosis drug, Prolia.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Amazon's First Customer Receipt Goes Viral, Bezos and Musk React
just now
Four Arrested for Selling P102 Million in Counterfeit Anti-Cancer Medicine in Makati
just now
Albanian MP Discusses Rising Prices, Stagnant Incomes, and EU Integration
11m ago
Oil Traffic Through Danish Straits Reaches Historic Highs, Raising Safety and Pollution Concerns
19m ago